News
5h
TipRanks on MSNAkero Therapeutics’ Phase 3 NASH Study: A Potential Game-Changer?
Akero Therapeutics (($AKRO)) announced an update on their ongoing clinical study. Akero Therapeutics is conducting a Phase 3 study titled A Phase ...
Individual brings two decades of industry experience to his new role, and has also previously worked at Refinitiv, Bloomberg ...
A new Equifax Canada report shows 1.4 million Canadians missed a credit payment in the second quarter. While that’s up by 118 ...
Manitoba’s near-top position likely results from its relatively low numbers, noted Rebecca Oakes, Equifax Canada vice-president of advanced analytics. The credit reporting agency tracked an average ...
Will Douglas has joined IMC Trading as a FX options trader. London-based Douglas brings previous experience in automated ...
A new Equifax® (NYSE:EFX) survey shows that human resources (HR) leaders are facing challenges using technology innovation to ...
Regional dynamics also show widening stress with Ontario’s non-mortgage delinquency rate rising to 1.75% led by Toronto, the ...
In Q2 2025, close to 1.4 million Canadians missed a credit payment — 7,000 fewer than last quarter – but still 118,000 more ...
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of ...
Rebecca Oakes, vice-president of advanced analytics at Equifax Canada, said it's "a bit of good news" to see the delinquency ...
Quality boots, weather systems, and field accessories were among the highlights of this year's product launches. Here’s what ...
Akero Therapeutics (AKRO) announced publication of 96-week final results from the Phase 2b HARMONY trial in The Lancet in adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results